SCHEMBL24718268

SCHEMBL24718268

O=C1CC(CN2C(=O)c3ccccc3C2=O)CN1Cc1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ CHRM5 P08912 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ P2RX7 Q99572 1/20 0.40
▸ ADRA1D P25100 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ ADRA1B P35368 1/20 0.40
▸ TRPC5 Q9UL62 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TACR1 P25103 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ TRPC4 Q9UBN4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718266 0.82 SIRT2 (0.48) CA12CA1CA9SIRT2SIRT1
SCHEMBL24719054 0.81 CA12 (0.45) CA12CA1CA9SIRT2SIRT1
SCHEMBL24718392 0.81 CA12 (0.45) CA12CA1CA9SIRT2SIRT1
SCHEMBL24718826 0.81 CA12 (0.45) CA12CA1CA9SIRT2SIRT1
SCHEMBL9456354 0.79 HPGD (0.54) KMT2AMEN1ALDH1A1ACHEDPP4
SCHEMBL24718625 0.79 CA12 (0.47) CA12CA9KMT2AATMKCNH2
SCHEMBL24718399 0.79 CA12 (0.47) CA12CA9KMT2AATMKCNH2
SCHEMBL11100770 0.77 CA12 (0.58) CA12CA1CA9CHRM5KMT2A
SCHEMBL24718393 0.76 SIRT2 (0.50) CA12CA1CA9SIRT2SIRT1
SCHEMBL24718411 0.76 SIRT2 (0.50) CA12CA1CA9SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 CA12 4697/4885CA1 4649/4885CA9 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback